武田制药 2026年年度报告和过渡报告

*Listed not for trading, but only in connection with the registration of the American Depositary Shares, pursuant to the requirements of the Securities and Exchange Commission.Securities registered or to be registered pursuant to Section12(g) of the Act:NoneSecurities for which there is a reporting obligation pursuant to Section15(d) of the Act:None___________________________________________________________ Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act.YesNo☐If this report is an annual or transition report, indicate by check mark if the registrant is not required tofile reports pursuant to Section13 or 15(d) of the Securities Exchange Act of 1934. Yes☐NoIndicate by check mark whether the registrant: (1)hasfiled all reports required to befiled by Section13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorterperiod that the registrant was required tofile such reports), and (2)has been subject to suchfiling requirements for the past 90days.YesNo☐Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of RegulationS-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit suchfiles).YesNo☐Indicate by check mark whether the registrant is a large acceleratedfiler, an acceleratedfiler, a non-acceleratedfiler, or an emerging growth company. See definition of “large acceleratedfiler,” “accelerated If an emerging growth company that prepares itsfinancial statements in accordance with U.S. GAAP, indicate by check mark if the registrant has elected not to use the extended transition period for complyingwith any new or revisedfinancial accounting standards provided pursuant to Section13(a) of the Exchange Act.☐† The term “new or revisedfinancial accounting standard” refers to any update issued by the Financial Accounting Standards Board to its Accounting Standards Codification after April5, 2012.† If securities are registered pursuant to Section 12(b) of the Act, indicate by check mark whether thefinancial statements of the registrant included in thefiling reflect the correction of an error to previouslyissuedfinancial statements.☐ Indicate by check mark whether any of those error corrections are restatements that required a recovery analysis of incentive-based compensation received by any of the registrant’s executive officers duringthe relevant recovery period pursuant to §240.10D-1(b).☐Indicate by check mark which basis of accounting the registrant has used to prepare thefinancial statements included in thisfiling: U.S.GAAP☐ International Financial Reporting Standards as issuedby the International Accounting Standards Board☒Other☐If “Other” has been checked in response to the previous question, indicate by check mark whichfinancial statement item the registrant has elected to follow.☐Item17☐Item18If this is an annual report, indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).Yes☐No☒(APPLICABLE ONLY TO ISSUERS INVOLVED IN BANKRUPTCY PROCEEDINGS DURING THE PAST FIVE YEARS)Indicate by check mark whether the registrant hasfiled all documents and reports required to befiled by Sections 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution ofsecurities under a plan confirmed by a court.Yes☐No☐ TABLE OF CONTENTS Special Note Regarding Forward-Looking StatementsPART IItem 1. Identity of Directors, Senior Management and AdvisersItem 2. Offer Statistics and Expected TimetableItem 3. Key Information3.A [Reserved]3.B Capitalization and Indebtedness3.C Reason for the Offer and Use of Proceeds3.D Risk FactorsItem 4. Information on the Company4.A History and Development of the Company4.B Business Overview4.C Organizational Structure4.D Property, Plant and EquipmentItem 4A. Unresolved StaffCommentsItem 5. Operating and Financial Review and Prospects5.A Operating Results5.B Liquidity and Capital Resources5.C Research and Development, Patents and Licenses, etc.5.D Trend Information5.E Critical Accounting EstimatesAnnex to Item 5. Certain Supplemental Non-IFRS Measures as Defined and Presented by TakedaItem 6. Directors, Senior Management and Employees6.A Directors and Senior Management6.B Compensation6.C Board Practices6.D Employees6.E Share Ownership6.F Disclosure of a Registrant’s Action to Recover Erroneously Awarded CompensationItem 7. Major Shareholders and Related Party Transactions7.A Major Shareholders7.B Related Party Transactions7.C Interest of Experts and CounselItem 8. Financial Information8.A Consolidated Statements and Other Financial Information8.B Significant ChangesItem 9. The Offer and Listing9.A Offer and Listing Details9.B Plan of Distribution9.C Markets9.D Selling Shareholders 9.E Dilution9.F Expenses of the IssueItem 10. Addi